Streetbeat News

Products Services

EBS

The FDA has approved Emergent BioSolutions' ACAM2000 vaccine for expanded use to prevent mpox in high-risk individuals. This approval is based on human safety data and animal studies. Emergent will donate 50,000 doses to Central Africa, and the vaccine is stockpiled in the U.S. and internationally. EBS stock rose 15.70% following the news.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 11:43 am

NVO

Novo Nordisk's new analysis published in The Lancet shows that semaglutide reduces the risk of cardiovascular death or worsening heart failure in patients with a history of heart failure.

Portfolio Pulse from Nabaparna Bhattacharya

August 30, 2024 | 11:41 am

BHP

The South Australian government has started reviewing BHP's proposed expansion of its Olympic Dam copper smelter and refinery. If approved, this expansion would significantly increase BHP's copper production, aligning with its strategy to enhance output in the region. BHP aims to double its current production by the mid-2030s, with a target of 650,000 tons per year. This expansion is part of BHP's broader strategy to capitalize on copper's role in the global energy transition.

Portfolio Pulse from Stjepan Kalinic

August 30, 2024 | 11:37 am

ALNY

Alnylam Pharmaceuticals' shares are declining following the announcement of results from its HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic for ATTR amyloidosis with cardiomyopathy.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 11:32 am

NCNA

NuCana shares fell after the company announced the discontinuation of its NuTide:323 study.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 11:17 am

LOT

Lotus Technology has obtained local homologation certification for its Eletre and Emeya models in the GCC region, with deliveries of the Eletre model expected in Q3.

Portfolio Pulse from Nabaparna Bhattacharya

August 30, 2024 | 11:11 am

JKS

JinkoSolar has announced its expected Q3 module shipments to be between 23.0 GW and 25.0 GW, and has reiterated its guidance for 2024 to be between 100.0 GW and 110.0 GW.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 10:34 am

RIVN

Rivian Automotive has launched a new referral program in the U.S. to reward customers who refer new buyers, similar to Tesla's scheme. The program offers points and charging benefits to both referrers and new buyers.

Portfolio Pulse from Anan Ashraf

August 30, 2024 | 10:25 am

ALNY

Alnylam Pharmaceuticals announced positive results from its HELIOS-B Phase 3 study of Vutrisiran, showing significant reductions in all-cause mortality and cardiovascular events.

Portfolio Pulse from Nabaparna Bhattacharya

August 30, 2024 | 10:07 am

TSLA

ZK

Zeekr, a Chinese EV manufacturer, is launching its first SUV, the Zeekr 7X, in China, priced lower than Tesla's Model Y. This move intensifies the price war in China's EV market, challenging Tesla's market position. Zeekr's aggressive pricing and technological advancements could impact Tesla's competitive edge.

Portfolio Pulse from Benzinga Neuro

August 30, 2024 | 10:01 am